{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Obstetrical and Gynecological Survey - Vol. 79, No. 10

Activity Steps

1 Activity
2 Take Test 3Certificate

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. CME Article 20: Provider Guidance for the Prevention of Respiratory Syncytial Virus in Infants: Maternal Vaccination Versus Infant Monoclonal Antibody Treatment -- Describe new maternal RSV vaccination and infant RSV monoclonal antibody to prevent lower respiratory tract infections due to RSV; analyze the research surrounding maternal RSV vaccination and infant monoclonal antibody administration; and initiate discussion with patients regarding their decision to proceed with maternal RSV vaccination and infant monoclonal antibody administration.
  2. CME Article 21: Diagnosis and Management of Preterm Prelabor Rupture of Membranes: A Comprehensive Review of Major Guidelines -- Describe the diagnostic methods of PPROM; (2) identify all the PPROM-related complications indicating immediate delivery; and (3) explain the appropriate management techniques of PPROM based on gestational age.
  3. CME Article 22: Implications of Prenatal Cannabis Exposure on Childhood Neurodevelopmental Outcomes: A Summary of the Clinical Evidence -- Describe the pharmacologic impacts of 9-tetrahydrocannabinol (THC) in pregnancy; discuss the existing clinical literature regarding impacts of prenatal cannabis use on fetal neurodevelopment; and explain how to provide evidence-based and patient-centered counseling on prenatal cannabis use.
  4. CME Article 23: Familial Mediterranean Fever in Pregnancy -- Describe the clinical significance and impact of FMF in pregnancy; explain the incidence, pathophysiology, diagnostic criteria, and treatment of FMF; and discuss genetic testing in the setting of a FMF diagnosis.

Disclosures

All authors, faculty, and staff have no relevant financial relationships with any ineligible organizations regarding this educational activity.

Price: $40.00

Credits:

  • ACCME 4.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 4.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planner
Professions: Physician
Test Code: OGS1024
Published: October 2024
Expires: 9/30/2026
Sources: Obstetrical & Gynecological Survey
Required Passing Score: 12/16 (75%)
Authors: Ashley A. Cirillo, DO and Stephanie L. Gaw, MD, PhD; Sonia Giouleka, MSc, Ioannis Tsakiridis, PhD, Garyfallia Emmanouilidou, MSc, Eirini Boureka, MSc, Ioannis Kalogiannidis, PhD, Apostolos Mamopoulos, PhD, Apostolos Athanasiadis, PhD, and Themistoklis Dagklis, PhD; Sydney Mei Sheffield, BSPH, Jeffrey A. Kuller, MD, Susan Kay Murphy, PhD, Sarah K. Dotters-Katz, MD, MMHPE, and Jordan Enns Schaumberg, MD; Alana Davidson, BS, Jeffrey A. Kuller, MD, Sarah K. Dotters-Katz, MD, MMPHE, and Rachel L. Wood, MD
Categories: Gynecological , Obstetrical
Specialties: Gynecology, OB/GYN
Topics: Familial Mediterranean Fever in Pregnancy , Prenatal Cannabis Exposure , Preterm Prelabor Rupture of Membranes , Respiratory Syncytial Virus in Infants